127 related articles for article (PubMed ID: 7622293)
21. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
Matsumoto SS; Yu J; Yu AL
J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
[TBL] [Abstract][Full Text] [Related]
22. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices.
Golembiowska K; White TD; Sawynok J
Eur J Pharmacol; 1996 Jun; 307(2):157-62. PubMed ID: 8832217
[TBL] [Abstract][Full Text] [Related]
23. Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2'-deoxycoformycin in beagle dogs.
Rodman LE; Farnell DR; Coyne JM; Allan PW; Hill DL; Duncan KL; Tomaszewski JE; Smith AC; Page JG
Toxicol Appl Pharmacol; 1997 Nov; 147(1):39-45. PubMed ID: 9356305
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.
Aldinucci D; Poletto D; Zagonel V; Rupolo M; Degan M; Nanni P; Gattei V; Pinto A
Br J Haematol; 2000 Jul; 110(1):188-96. PubMed ID: 10930997
[TBL] [Abstract][Full Text] [Related]
25. Inability of poly-ADP-ribosylation inhibitors to protect peripheral blood lymphocytes from the toxic effects of ADA inhibition.
Ganeshaguru K; Piga A; Latini L; Hoffbrand AV
Adv Exp Med Biol; 1989; 253B():251-8. PubMed ID: 2532859
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
Kuroki Y; Shimoyama M; Inaba S; Hirose M
Jpn J Cancer Res; 1989 May; 80(5):482-9. PubMed ID: 2502523
[TBL] [Abstract][Full Text] [Related]
27. Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor.
Poon A; Sawynok J
Eur J Pharmacol; 1999 Nov; 384(2-3):123-38. PubMed ID: 10611432
[TBL] [Abstract][Full Text] [Related]
28. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
Thuillier L; Garreau F; Cartier PH
Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
[TBL] [Abstract][Full Text] [Related]
29. 5'-Deoxyadenosine metabolism in various mammalian cell lines.
Plagemann PG; Wohlhueter RM
Biochem Pharmacol; 1983 Apr; 32(8):1433-40. PubMed ID: 6602613
[TBL] [Abstract][Full Text] [Related]
30. The combination of adenosine deaminase inhibition and deoxyadenosine induces apoptosis in a human astrocytoma cell line.
Garcia-Gil M; Tozzi MG; Varani S; Della Verde L; Petrotto E; Balestri F; Colombaioni L; Camici M
Neurochem Int; 2015 Jan; 80():14-22. PubMed ID: 25447764
[TBL] [Abstract][Full Text] [Related]
31. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
Kang GJ; Kimball AP
Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
[TBL] [Abstract][Full Text] [Related]
32. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
Wolberg G; Zimmerman TP
Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
[TBL] [Abstract][Full Text] [Related]
33. Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Niitsu N; Yamaguchi Y; Umeda M; Honma Y
Blood; 1998 Nov; 92(9):3368-75. PubMed ID: 9787175
[TBL] [Abstract][Full Text] [Related]
34. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.
Hashemi M; Karami-Tehrani F; Ghavami S; Maddika S; Los M
Cell Prolif; 2005 Oct; 38(5):269-85. PubMed ID: 16202036
[TBL] [Abstract][Full Text] [Related]
35. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS
Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
[TBL] [Abstract][Full Text] [Related]
36. Renal handling of 2'-deoxyadenosine and adenosine in humans and mice.
Kuttesch JF; Nelson JA
Cancer Chemother Pharmacol; 1982; 8(2):221-9. PubMed ID: 6980741
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of similarities and differences in neurotoxicities caused by adenosine and 2'-deoxyadenosine in sympathetic neurons.
Kulkarni JS; Wakade AR
J Neurochem; 1996 Aug; 67(2):778-86. PubMed ID: 8764607
[TBL] [Abstract][Full Text] [Related]
38. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
Helland S; Ueland PM
Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
[TBL] [Abstract][Full Text] [Related]
39. Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes.
Scharenberg JG; Rijkers GT; Akkerman JW; Staal GE; Zegers BJ
Int J Immunopharmacol; 1990; 12(1):113-20. PubMed ID: 2303314
[TBL] [Abstract][Full Text] [Related]
40. Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse.
Knudsen TB; Winters RS; Otey SK; Blackburn MR; Airhart MJ; Church JK; Skalko RG
Teratology; 1992 Jan; 45(1):91-103. PubMed ID: 1731400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
